Skip to main content
Premium Trial:

Request an Annual Quote

Jury Says Stratagene Willfully Infringed Third Wave s Patents, Awards $5.3M in Damages

NEW YORK, Sept. 7 (GenomeWeb News) - A jury has found that Stratagene has willfully infringed two nucleic acid testing patents held by Third Wave Technologies, and has awarded Third Wave $5.3 million in damages, Third Wave said yesterday.

 

Last week, the jury determined that Stratagene's FullVelocity quantitative PCR and RT-PCR products infringe the two patents.

 

Third Wave said it will seek additional damages based on the willfulness of the infringement of the patents, which are the basis for its Invader nucleic acid-testing chemistry. The company also seeks a permanent injunction and destruction of Stratagene's infringing FullVelocity reagents.

 

Stratagene said on Monday that it will appeal the jury's verdict.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.